D-1851-2019 Class III Terminated
FDA drug recall D-1851-2019 was initiated by Macleods Pharma Usa Inc on Aug 21, 2019 and is designated Class III. Reason for recall: Subpotent Drug: Out of specification result during stability study in Pramipexole Dihydrochloride Tablets 0.125 mg The recall status is terminated (terminated Jan 28, 2021). Affected quantity: 1837 90-count bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Sep 18, 2019
- Initiation Date
- Aug 21, 2019
- Termination Date
- Jan 28, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1837 90-count bottles
Product description
Pramipexole Dihydrochloride Tablets 0.125 mg,90-count bottle, Rx Only, Manufactured for: Macleods Pharma USA, Inc. Plainsboro, NJ 08536, Manufactured by: Macleods Phamaceuticals Ltd. Baddi Himachal Pradesh, India. NDC 33342-031-10
Reason for recall
Subpotent Drug: Out of specification result during stability study in Pramipexole Dihydrochloride Tablets 0.125 mg
Distribution pattern
Distributed Nationwide in the USA
Code information
Lot #BPA801A, EXP 12/2020
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1851-2019
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026